119 related articles for article (PubMed ID: 15224305)
1. Cardiovascular drugs: adenosine role in coronary syndromes and percutaneous coronary interventions.
Rosales OR; Eades B; Assali AR
Catheter Cardiovasc Interv; 2004 Jul; 62(3):358-63. PubMed ID: 15224305
[TBL] [Abstract][Full Text] [Related]
2. The cardiovascular effects of adenosine: clinical use and nursing implications.
Teplitz L
Prog Cardiovasc Nurs; 1993; 8(2):20-8. PubMed ID: 7937680
[TBL] [Abstract][Full Text] [Related]
3. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
[TBL] [Abstract][Full Text] [Related]
4. Intracoronary boluses of adenosine and sodium nitroprusside in combination reverses slow/no-reflow during angioplasty: a clinical scenario of ischemic preconditioning.
Parikh KH; Chag MC; Shah KJ; Shah UG; Baxi HA; Chandarana AH; Naik AM; Shah JN; Shah HD; Goyal RK
Can J Physiol Pharmacol; 2007; 85(3-4):476-82. PubMed ID: 17612657
[TBL] [Abstract][Full Text] [Related]
5. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory.
Rezkalla SH; Kloner RA
Catheter Cardiovasc Interv; 2008 Dec; 72(7):950-7. PubMed ID: 19021281
[TBL] [Abstract][Full Text] [Related]
6. API expert consensus document on management of ischemic heart disease.
Association of Physicians of India
J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
[TBL] [Abstract][Full Text] [Related]
7. Emergency percutaneous coronary intervention (PCI) for the care of patients with ST-elevation myocardial infarction (STEMI).
Morrison DA; Berman M; El-Amin O; McLaughlin RT; Bates ER
Minerva Cardioangiol; 2007 Oct; 55(5):593-623. PubMed ID: 17912165
[TBL] [Abstract][Full Text] [Related]
8. Pharmaceutical interventions for the management of no-reflow.
Fischell TA
J Invasive Cardiol; 2008 Jul; 20(7):374-9. PubMed ID: 18599901
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial.
Amit G; Cafri C; Yaroslavtsev S; Fuchs S; Paltiel O; Abu-Ful A; Weinstein JM; Wolak A; Ilia R; Zahger D
Am Heart J; 2006 Nov; 152(5):887.e9-14. PubMed ID: 17070151
[TBL] [Abstract][Full Text] [Related]
10. [Study of no-reflow phenomenon after reperfusion for acute myocardial infarction].
Yang YJ; Zhao JL
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2169-70. PubMed ID: 16321176
[No Abstract] [Full Text] [Related]
11. Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.
J E; Juneja MS; George T; Sr R; V V; Ak B; Kalyani S; Pandurangi UM; Latchumanadhas K; S MA
Indian Heart J; 2007; 59(3):246-9. PubMed ID: 19124934
[TBL] [Abstract][Full Text] [Related]
12. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation.
Ono H; Osanai T; Ishizaka H; Hanada H; Kamada T; Onodera H; Fujita N; Sasaki S; Matsunaga T; Okumura K
Am Heart J; 2004 Oct; 148(4):E15. PubMed ID: 15459610
[TBL] [Abstract][Full Text] [Related]
13. Comparison of combination therapy of adenosine and nitroprusside with adenosine[correction for adensosine] alone in the treatment of angiographic no-reflow phenomenon: does 1 plus 1 equal 11?
Bailey SR
Catheter Cardiovasc Interv; 2004 Apr; 61(4):492-3. PubMed ID: 15065144
[No Abstract] [Full Text] [Related]
14. Letter of comment on "Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial" (Am Heart J 2006;152:887.e9-14).
Vydt T; Agostoni P
Am Heart J; 2007 May; 153(5):e25; author reply e27. PubMed ID: 17452140
[No Abstract] [Full Text] [Related]
15. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
[TBL] [Abstract][Full Text] [Related]
16. [No-reflow phenomenon occurring during elective angioplasty performed due to in-stent restenosis -- a case report].
Dobrzycki S; Nowak K; Kozuch M; Bachórzewska-Gajewska H; Poniatowski B; Zuk J
Kardiol Pol; 2006 Apr; 64(4):437-40. PubMed ID: 16699996
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous coronary intervention and the no-reflow phenomenon.
van Gaal WJ; Banning AP
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):715-31. PubMed ID: 17605650
[TBL] [Abstract][Full Text] [Related]
18. Optimizing revascularization strategies in patients with multivessel coronary disease: impact of intracoronary pressure measurements.
Lindstaedt M; Fritz MK; Yazar A; Perrey C; Germing A; Grewe PH; Laczkovics AM; Mügge A; Bojara W
J Thorac Cardiovasc Surg; 2005 Apr; 129(4):897-903. PubMed ID: 15821661
[TBL] [Abstract][Full Text] [Related]
19. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction.
Pasceri V; Pristipino C; Pelliccia F; Granatelli A; Speciale G; Roncella A; Pironi B; Capasso M; Richichi G
Am J Cardiol; 2005 Jun; 95(11):1358-61. PubMed ID: 15904643
[TBL] [Abstract][Full Text] [Related]
20. The no-reflow phenomenon: epidemiology, pathophysiology, and therapeutic approach.
Alfayoumi F; Srinivasan V; Geller M; Gradman A
Rev Cardiovasc Med; 2005; 6(2):72-83. PubMed ID: 15976730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
